s6y Virax Biolabs Group Ltd EFFECT

Virax Biolabs Group Ltd EFFECT, filed Sep 3, 2026: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 3, 2026 4:00 P.M.
Form: F-3
CIK: 0001885827
Company Name: Virax Biolabs Group Ltd
File Number: 333-297684